Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

If there's something that could save us from annihilation, it's definitely NOT AT-014.
The extended field study was started 02/15/18, and the recruitment should be complete by 02/15/19:
https://ebusiness.avma.org/aahsd/study_search_detail.aspx?sid=4607&rel=0
Since the median survival time was 965 days for the initial trials on 18 dogs, it's reasonable to expect that they would like to see median survival time for the extended group, for higher p-value. Thus, it would take about 3 years to see the data once the recruitment is complete. That's about February '22. There's no chance on Earth the company would survive until then relying just on AT-014 milestones. Someone else would be harvesting the fruits of this vaccine.